| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/20/2007 | US7179906 Asymmetric benzoxanthene dyes |
| 02/20/2007 | US7179905 Nucleic acid labeling compounds |
| 02/20/2007 | US7179904 Useful for modulating transcription of a desired polynucleotide |
| 02/20/2007 | US7179903 Liver specific transcriptional enhancer |
| 02/20/2007 | US7179902 Use of regulatory sequences in transgenic plants |
| 02/20/2007 | US7179901 Renal regulatory elements and methods of use thereof |
| 02/20/2007 | US7179898 Human vanilloid receptor-like receptor |
| 02/20/2007 | US7179896 Method of making PNA oligomers |
| 02/20/2007 | US7179895 Rat calcium channel subunits and related probes, cell lines and methods |
| 02/20/2007 | US7179894 Detection of preferential aptamer in sample; generate oligonucleotide, incubate with primer and polymerase, amplify and recover nucleotide sequences |
| 02/20/2007 | US7179892 Humanized antibodies that recognize beta amyloid peptide |
| 02/20/2007 | US7179889 Propionicin T1 polypeptide, a bacteriocin from Propionibacterium thoenii |
| 02/20/2007 | US7179888 Antigenic, non-toxic mutants of Clostridium septicum alpha toxin and vaccines, antibodies, sera, and methods of treatment therewith |
| 02/20/2007 | US7179887 Protein with a molecular weight of between 41 55 kD; useful for the development of models of human platelet aggregation |
| 02/20/2007 | US7179884 Polypeptides; proteolysis splitting; antitumor agents |
| 02/20/2007 | US7179874 Chain extended polyetherurethane derived from a carboxy-functional diisocyanate modified with an amino compound to form 3-aminoalkylamide linkages; units of ethylene glycol, lysine diisocyanate, N,N-diethylethylenediamine, and N-methyldiethanolamine for example; for gene delivery |
| 02/20/2007 | US7179797 Methods and compositions for treating prostate cancer using DNA vaccines |
| 02/20/2007 | US7179796 Protein phosphatase 1B; oligonucleotide of 8-50 nucleobases targeted to a nucleic acid molecule encoding PTP1B; specifically hybridizes with and inhibits the expression of PTP1B. |
| 02/20/2007 | US7179795 Nucleic acids encoding chimeric proteins comprising BMP-2 and a proteinase inhibitor |
| 02/20/2007 | US7179790 Brain natriuretic peptide |
| 02/20/2007 | US7179786 Variants of the NK1 fragment of hepatocyte growth factor/scatter factor (HGF/SF) and their use |
| 02/20/2007 | US7179660 Useful in diagnostic and therapeutic methods |
| 02/20/2007 | US7179650 Providing, in vitro, the cell with a nucleic acid segment encoding a polypeptide comprising wherein a Fas and/or TNFR1 mediated apoptosis pathway is inhibited in the cell |
| 02/20/2007 | US7179648 Susceptible to baculovirus infection, useful for replicating, for gene expression using a baculovirus expression system |
| 02/20/2007 | US7179647 For introducing DNA into organisms which produce large amounts of oils and, in particular, oils with a high content of unsaturated fatty acids |
| 02/20/2007 | US7179646 Useful for obtaining tumour-selective gene expression in tumours having a mutated beta -catenin pathway; used to express genes encoding therapeutic proteins in colorectal cancer cells |
| 02/20/2007 | US7179645 Hybrid polypeptide; induce immunology response, antiallergens; major histocompatibility complex; vaccine |
| 02/20/2007 | US7179644 Kit for use in the generation of preferential expression vectors |
| 02/20/2007 | US7179634 Methods for producing a polypeptide in a Bacillus cell |
| 02/20/2007 | US7179631 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog |
| 02/20/2007 | US7179630 Thermostable proteases |
| 02/20/2007 | US7179629 For therapy and prophylaxis of cancer, diabetes, neurological disorders, cardiovascular disorders, musculo-skeletal disorders, inflammatory disorders, genitourological disorders, and respiratory disorders (e.g., asthma and COPD) |
| 02/20/2007 | US7179628 Transglutaminase |
| 02/20/2007 | US7179627 Cyclooxygenase variants and methods of use |
| 02/20/2007 | US7179626 Changing the amino acid at position 576 of SEQ ID NO: 3 to a Phe residue, whereupon the specificity of the potato tuber lipoxygenase for position 11 of arachidonic acid is enhanced |
| 02/20/2007 | US7179623 Method of producing amino acids using E. coli transformed with sucrose PTS genes |
| 02/20/2007 | US7179622 Recombinant DNA formed by ligating; gene expression; suppressing proliferation; medicine/drugs |
| 02/20/2007 | US7179621 Pigment epithelium-derived factor: sequence of the PEDF gene |
| 02/20/2007 | US7179620 Elongation of fatty acids(ELF) polypeptides and carrier mixtures administered for prophylaxis of vision defects |
| 02/20/2007 | US7179618 Streptavidin proteins |
| 02/20/2007 | US7179608 Therapeutic antiangiogenic compositions and methods |
| 02/20/2007 | US7179604 Methods of use of DNA encoding a human histamine receptor of the H3 subtype |
| 02/20/2007 | US7179603 Detection and identification of enteric bacteria |
| 02/20/2007 | US7179601 Methods of identifying plant disease-resistance genes |
| 02/20/2007 | US7179600 Oligonucleotide chip composition and a method for analyzing a hepatitis C virus genotype using the composition |
| 02/20/2007 | US7179599 Mobilization of viral genomes from T-DNA using site-specific recombination systems |
| 02/20/2007 | US7179597 Genetic diagnosis for QT prolongation related adverse drug reactions |
| 02/20/2007 | US7179594 Method for distinguishing 5-position methylation changes of cytosine bases and cytosine-to-thymine mutations and for detecting single nucleotide polymorphisms (SNPs) or point mutations in genomic DNA |
| 02/20/2007 | US7179593 Estrogen receptor site-specific ribozymes and uses thereof for estrogen dependent tumors |
| 02/20/2007 | US7179590 High temperature reverse transcription using mutant DNA polymerases |
| 02/20/2007 | US7179589 Single stranded DNA sequence hybridizes an oligonucleotide or DNA analogue and then complexes with a marker; output signals are measured for formation and dissociation indications |
| 02/20/2007 | US7179472 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 02/20/2007 | US7179470 Hepatitis-C virus testing |
| 02/20/2007 | US7179467 DCMP2 polypeptide |
| 02/20/2007 | US7179465 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type 1 interferon |
| 02/20/2007 | US7179463 Treatment of alzheimer's disease |
| 02/20/2007 | US7179462 α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof |
| 02/20/2007 | US7179459 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 02/20/2007 | US7179458 Lactobacilli expressing biologically active polypeptides and uses thereof |
| 02/20/2007 | US7179457 Modified to include heterologous insertion downstream of its replicase open reading frames; insertion preferably comprises one or more protein-coding regions ideal for virus-like particles packaging |
| 02/20/2007 | US7179456 Use of parvovirus for brain tumor therapy |
| 02/20/2007 | US7179448 Recombinant constructs of Borrelia burgdorferi |
| 02/20/2007 | CA2351634C Thermostable enzyme promoting the fidelity of thermostable dna polymerases- for improvement of nucleic acid synthesis and amplification in vitro |
| 02/20/2007 | CA2346997C Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 02/20/2007 | CA2321645C Dna sequences containing a conjugative transfer mechanism |
| 02/20/2007 | CA2289979C Methods of modulating immune coagulation |
| 02/20/2007 | CA2230975C Wheat aleurone promoter |
| 02/20/2007 | CA2193210C Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen |
| 02/20/2007 | CA2175628C Production of recombinant factor viii in the presence of liposome-like substances of mixed composition |
| 02/20/2007 | CA2133956C Dna sequencing method |
| 02/18/2007 | CA2556456A1 Method of regulation of bacterial persister status |
| 02/15/2007 | WO2007019444A2 Subtractive separation and amplification of non-ribosomal transcribed rna (nrrna) |
| 02/15/2007 | WO2007019442A2 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
| 02/15/2007 | WO2007019247A2 Virus-like particles as vaccines for paramyxovirus |
| 02/15/2007 | WO2007019190A2 Role of gax in alzheimer neurovascular dysfunction |
| 02/15/2007 | WO2007018853A2 Secretion of antibodies without signal peptides from bacteria |
| 02/15/2007 | WO2007018602A1 Isolation of cpg islands by thermal segregation and enzymatic selection-amplification method |
| 02/15/2007 | WO2007018562A2 Nanospearing for molecular transportation into cells |
| 02/15/2007 | WO2007018544A2 Tri-block copolymers for nanosphere-based drug delivery |
| 02/15/2007 | WO2007018475A1 Novel anticoagulant polypeptides and complex |
| 02/15/2007 | WO2007018437A1 Methods of modulating apoptosis and platelet production using variants of cytochrome c |
| 02/15/2007 | WO2007018322A1 Gene therapeutic agent of cancer comprising recombinant adeno-associated virus containing antisense cdnas of vegf-a, vegf-b and vegf-c and recombinant adeno-associated virus containing vegfr truncated soluble cdna |
| 02/15/2007 | WO2007018318A1 Method for gene expression specific to cerebellar astrocyte and/or basket cell |
| 02/15/2007 | WO2007018315A1 Protein probe for use in detection of interaction between the protein and other molecule |
| 02/15/2007 | WO2007018310A1 A METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE ENTEROBACTERIACEAE FAMILY WITH ATTENUATED EXPRESSION OF THE ybiV GENE |
| 02/15/2007 | WO2007018309A1 Method for evaluating compound using molecule on the rb pathway as index and molecular diagnostic method |
| 02/15/2007 | WO2007018307A1 Phosphoadenylyl sulfate reductase gene and use thereof |
| 02/15/2007 | WO2007018282A1 Method of determining a biospecies |
| 02/15/2007 | WO2007018257A1 Method of detecting large bowel cancer marker |
| 02/15/2007 | WO2007018238A1 Method of screening apoptosis accelerating compound or anti-apoptotic compound and method of determining malignancy of neurodegenerative disease |
| 02/15/2007 | WO2007018236A1 Screening method for compound inhibiting development or progression of familial amyotrophic lateral sclerosis and diagnostic method for familial amyotrophic lateral sclerosis |
| 02/15/2007 | WO2007018199A1 Cancer-rejection antigen peptide derived from glypican-3 (gpc3) for use in hal-a2-positive patient and pharmaceutical comprising the antigen |
| 02/15/2007 | WO2007018198A1 Cancer-rejection antigen peptide derived from hsp105 for use in hal-a2-positive patient and pharmaceutical comprising the antigen |
| 02/15/2007 | WO2007018182A1 Cancer-like mutant |
| 02/15/2007 | WO2007018169A1 Method for detection of inosine-containing site in rna |
| 02/15/2007 | WO2007018143A1 Use of gene which varies in amount of expression during the course of transition from precancer to cancer |
| 02/15/2007 | WO2007018062A1 Eucalyptus globulus monoterpene synthetase gene |
| 02/15/2007 | WO2007018049A1 Antigen capable of inducing neutralizing antibody for high risk-type human papillomavirus |
| 02/15/2007 | WO2007018047A1 Squamous cell carcinoma antigen-derived peptide binding to hla-a24 molecule |
| 02/15/2007 | WO2007017903A2 Expression vector and methods of producing high levels of proteins |